Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-04, Stock:ABBV, The news for the past five days is as follows:
2019-01-28: NEWS1: AbbVie Missed Revenue Estimates in Q4 2018.NEWS2: Health Care Sector Update for 01/28/2019: ABBV,ALXN,TRVN,ARAY.NEWS3: Health Care Sector Update for 01/28/2019: ABBV,ALXN,TRVN,ARAY.NEWS4: What Are Analysts Recommending for AbbVie after Q4 2018 Results?.NEWS5: Monday Sector Laggards: Energy, Healthcare.NEWS6: Monday Sector Laggards: Energy, Healthcare.NEWS7: Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN.NEWS8: Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN.NEWS9: Is AbbVie in Hot Water?.NEWS10: This is Why AbbVie (ABBV) is a Great Dividend Stock.NEWS11: This is Why AbbVie (ABBV) is a Great Dividend Stock.NEWS12: The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck.NEWS13: The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck.NEWS14: Analysts Cut AbbVie Price Targets After Earnings Miss.NEWS15: 5 Dividend Growth Stocks With Upside To Analyst Targets.NEWS16: 5 Dividend Growth Stocks With Upside To Analyst Targets.NEWS17: Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN.NEWS18: The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck.NEWS19: Health Care Sector Update for 01/28/2019: TRVN, ARAY, ABBV, JNJ, PFE, ABT, MRK, AMGN.NEWS20: Health Care Sector Update for 01/28/2019: TRVN, ARAY, ABBV, JNJ, PFE, ABT, MRK, AMGN.NEWS21: This is Why AbbVie (ABBV) is a Great Dividend Stock.NEWS22: AbbVie Announces U.S. FDA Approval of IMBRUVICA® (ibrutinib) Plus Obinutuzumab (GAZYVA®) - First Chemotherapy-Free, Anti-CD20 Combination Regimen Approved for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in Previously Untreated Patients.NEWS23: AbbVie Falls 3%.NEWS24: What's Making News In These Pharma And Cannabis Stocks Today?.NEWS25: What's Making News In These Pharma And Cannabis Stocks Today?.NEWS26: 3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore.NEWS27: 3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore.NEWS28: 3 Reasons AbbVie Investors Aren&apos;t Too Worried About Humira Anymore.
2019-01-29: NEWS1: Cramer's lightning round: AbbVie needs to make an acquisition—it might just save its stock.NEWS2: AbbVie (ABBV) Gains As Market Dips: What You Should Know.NEWS3: 10 Value Stocks to Buy for 2019 and Beyond.NEWS4: Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y.NEWS5: Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y.NEWS6: Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y.NEWS7: AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting.NEWS8: AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting.NEWS9: 3 Top Dividend Stocks to Buy Right Now.NEWS10: 3 Top Dividend Stocks to Buy Right Now.NEWS11: Jacksonville's increasing use of LNG as a transportation fuel.NEWS12: Imbruvica Is Key Growth Driver for AbbVie in Fiscal 2019.NEWS13: 3 Top Dividend Stocks to Buy Right Now.NEWS14: Health Care Sector Update for 01/29/2019: ARAY, TRVN, ABBV, JNJ, PFE, ABT, MRK, AMGN.NEWS15: Health Care Sector Update for 01/29/2019: ARAY, TRVN, ABBV, JNJ, PFE, ABT, MRK, AMGN.NEWS16: AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting.NEWS17: Why Humira Revenues in International Markets Are Expected to Fall.NEWS18: AbbVie Missed EPS Estimates in Q4 2018.NEWS19: The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive.
2019-01-30: NEWS1: 10 Value Stocks to Buy for 2019 and Beyond.NEWS2: 10 Value Stocks to Buy for 2019 and Beyond.NEWS3: ABBV Stock Is Worth a Look at Multi-Year Lows.NEWS4: ABBV Stock Is Worth a Look at Multi-Year Lows.NEWS5: 3 Big Pharmas Expecting a Softer 2019.NEWS6: 3 Big Pharmas Expecting a Softer 2019.NEWS7: ABBV Stock Is Worth a Look at Multi-Year Lows.NEWS8: Genentech kills big drug study in early Alzheimer's patients.NEWS9: AbbVie Reports Improvement in Margins in Fiscal 2018.NEWS10: 3 Big Pharmas Expecting a Softer 2019.NEWS11: A Look at AbbVie’s Diversified Product Portfolio in Fiscal 2019.NEWS12: Jim Cramer Gives His Opinion On AbbVie, Idexx Labs And More.NEWS13: Edited Transcript of ABBV earnings conference call or presentation 25-Jan-19 2:00pm GMT.NEWS14: AbbVie (ABBV) Gains As Market Dips: What You Should Know.NEWS15: AbbVie (ABBV) Gains As Market Dips: What You Should Know.
2019-01-31: NEWS1: Top Research Reports for Union Pacific, AbbVie & General Dynamics.NEWS2: 3 Top Large-Cap Stocks to Buy in February.NEWS3: 3 Top Large-Cap Stocks to Buy in February.
2019-02-01: NEWS1: Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance.NEWS2: Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance.NEWS3: Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance.NEWS4: Notable ETF Inflow Detected - XLV, AMGN, ABBV, LLY.NEWS5: Notable ETF Inflow Detected - XLV, AMGN, ABBV, LLY.NEWS6: Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY.NEWS7: Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY.NEWS8: The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics.NEWS9: The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics.NEWS10: The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics.NEWS11: Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY.NEWS12: Watch These Healthcare Stocks in First Week of February.NEWS13: The 12 Best Dividend Aristocrats- Part 1.

Answer: Decrease